Related Experiment Video
Updated: Dec 29, 2025

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
Published on: November 1, 2012
Cardiac Myosin Binding Protein-C Phosphorylation Mitigates Age-Related Cardiac Dysfunction: Hope for Better Aging?
Paola C Rosas1, Chad M Warren1, Heidi A Creed2
1Department of Physiology and Biophysics, Center for Cardiovascular Research, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Abstract:
Cardiac myosin binding protein-C (cMyBP-C) phosphorylation prevents aging-related cardiac dysfunction. We tested this hypothesis by aging genetic mouse models of hypophosphorylated cMyBP-C, wild-type equivalent, and phosphorylated-mimetic cMyBP-C for 18 to 20 months. Phosphorylated-mimetic cMyBP-C mice exhibited better survival, better preservation of systolic and diastolic functions, and unchanging wall thickness. Wild-type equivalent mice showed decreasing cMyBP-C phosphorylation along with worsening cardiac function and hypertrophy approaching those found in hypophosphorylated cMyBP-C mice. Intact papillary muscle experiments suggested that cMyBP-C phosphorylation increased cross-bridge detachment rates as the underlying mechanism. Thus, phosphorylating cMyBP-C is a novel mechanism with potential to treat aging-related cardiac dysfunction.
Insights
Phosphorylating cardiac myosin binding protein-C (cMyBP-C) prevents age-related heart dysfunction. This study shows phosphorylated-mimetic cMyBP-C mice maintained better heart function and survival, suggesting a therapeutic target.
Area of Science:
- Cardiology
- Molecular Biology
- Aging Research
Background:
- Aging leads to cardiac dysfunction, a significant health concern.
- Cardiac myosin binding protein-C (cMyBP-C) is crucial for heart muscle contraction.
- Phosphorylation of cMyBP-C is a potential regulator of cardiac function during aging.
Purpose of the Study:
- To investigate whether cMyBP-C phosphorylation prevents aging-related cardiac dysfunction.
- To determine the functional consequences of altered cMyBP-C phosphorylation in aging mouse models.
Main Methods:
- Aging of genetic mouse models with hypophosphorylated, wild-type equivalent, and phosphorylated-mimetic cMyBP-C for 18-20 months.
- Assessment of cardiac function, including systolic and diastolic parameters, and cardiac hypertrophy.
- Intact papillary muscle experiments to elucidate the underlying molecular mechanisms.
Main Results:
- Mice with phosphorylated-mimetic cMyBP-C showed improved survival, preserved systolic and diastolic functions, and stable wall thickness.
- Wild-type equivalent mice exhibited decreased cMyBP-C phosphorylation with worsening cardiac function and hypertrophy.
- Phosphorylation of cMyBP-C was linked to increased cross-bridge detachment rates.
Conclusions:
- cMyBP-C phosphorylation is a key mechanism that prevents aging-related cardiac dysfunction.
- Targeting cMyBP-C phosphorylation represents a novel therapeutic strategy for age-related heart disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Cross-bridge Cycle
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

